Effects of cranberry extracts on growth and biofilm production of escherichia coli and staphylococcus species

Phytotherapy Research

Volumn 26, Issue 9, 2012, Pages 1371-1374

  Laplante, Kerry L ^a,b   Sarkisian, Simon A ^a,b   Woodmansee, Suzanne ^a,b   Rowley, David C ^a   Seeram, Navindra P ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

biofilm; cranberry phytochemicals; Escherichia coli; Staphylococcus; Vaccinium macrocarpon

Indexed keywords

CRANBERRY EXTRACT; PROANTHOCYANIDIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERIDICAL CONCENTRATION; MINIMUM BIOFILM ERADICATION CONCENTRATION; MINIMUM BIOFILM INHIBITORY CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHYTOCHEMISTRY; STANDARDIZATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS SAPROPHYTICUS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; ESCHERICHIA COLI; FRUIT; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PROANTHOCYANIDINS; STAPHYLOCOCCUS; VACCINIUM MACROCARPON;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS SAPROPHYTICUS; VACCINIUM MACROCARPON;

EID: 84866066759     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4592     Document Type: Article

References (21)

1. Ando E, Monden K, Mitsuhata R, Kariyama R, Kumon H,. 2004. Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama 58: 207-214.
2. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A,. 1999. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 1771-1776.
3. CLSI. 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Eighth Edition. CLSI document M07-A8. Clinical and Laboratory Standards Institute: Wayne, PA.
4. Di Martino P, Agniel R, Gaillard JL, Denys P,. 2005. Effects of cranberry juice on uropathogenic Escherichia coli in vitro biofilm formation. J Chemother 17: 563-565.
5. Ferrieres L, Hancock V, Klemm P,. 2007. Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation. FEMS Immunol Med Microbiol 51: 212-219.
6. Howell AB,. 2007. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res 51: 732-737.
7. Howell AB, Botto H, Combescure C, et al., 2010. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 10: 94.
8. Jepson RG, Craig JC,. 2008. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 23: CD001321.
9. LaPlante KL, 2009. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strain. Agents Chemother 53: 3166-3169.
10. Leshem R, Maharshak I, Ben Jacob E, Ofek I, Kremer I,. 2011. The effect of nondialyzable material (NDM) cranberry extract on formation of contact lens biofilm by Staphylococcus epidermidis. Invest Ophthalmol Vis Sci 52: 4929-4934.
11. Mehall JR, Saltzman DA, Jackson RJ, Smith SD,. 2002. Fibrin sheath enhances central venous catheter infection. Crit Care Med 30: 908-912.
12. Mermel LA, Allon M, Bouza E, et al., 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49: 1-45.
13. Nowack R, Schmitt W,. 2008. Cranberry juice for prophylaxis of urinary tract infections-conclusions from clinical experience and research. Phytomedicine 15: 653-667.
14. Schmidt DR, Sobota AE,. 1988. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 55: 173-181.
15. Seeram NP, Adams LS, Hardy ML, Heber D,. 2004. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 52: 2512-2517.
16. Sobota AE,. 1984. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 131: 1013-1016.
17. Steinberg D, Feldman M, Ofek I, Weiss EI,. 2005. Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Antimicrob Agents 25: 247-251.
18. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M,. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40: 175-179.
19. Stothers L,. 2002. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 9: 1558-1562.
20. Tao Y, Pinzon-Arango PA, Howell AB, Camesano TA,. 2011. Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. J Med Food 14: 739-745.
21. Tian F, Li B, Ji B, et al., 2009. Antioxidant and antimicrobial activities of consecutive extracts from Galla chinensis: The polarity affects the bioactivities. Food Chem 113: 173-179.